Fig. 1 | Scientific Reports

Fig. 1

From: Pan-cancer analysis identifies ADAM12 as a prognostic biomarker and indicator of immune infiltration in glioma

Fig. 1

Pan-cancer analysis of ADAM12 expression. (A) ADAM12 expression levels across various cancer types, including both tumor and normal tissues, based on data from TCGA and GTEx datasets. (B) ADAM12 expression in tumor cell lines from the CCLE dataset. (C) Expression of ADAM12 in diverse cancer cell lines as derived from the HPA dataset. (D) ADAM12 expression in brain cancer cell lines from the HPA dataset. (E) Cellular localization of ADAM12 as observed in the HPA database (*p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001).

Back to article page